Veterinary Vaccines Market Report 2026

Veterinary Vaccines Market Overview

• Veterinary Vaccines market size has reached to $12.54 billion in 2025 • Expected to grow to $16.79 billion in 2030 at a compound annual growth rate (CAGR) of 6% • Growth Driver: Elevated Disease Prevalence Fuels Growth In The Veterinary Vaccines Market • Market Trend: Product Innovations Transforming The Veterinary Vaccine Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Veterinary Vaccines Market?

Veterinary vaccine refers to a biological preparation that stimulates the immune response of an animal against disease in order to reduce animal suffering and the transmission of microorganisms in the animal population and enhance the immunity power of animals by improving animal health, which also prevents the transmission of diseases from animals to humans. The various types of veterinary vaccines are live attenuated vaccines, inactivated vaccines, toxoid vaccines, recombinant vaccines, and other vaccine types. Inactivated vaccines differ from live but attenuated vaccines as they are made up of dead, or inactivated, viruses and bacteria. The disease types are anaplasmosis, canine parvovirus, foot and mouth disease, Newcastle disease, distemper disease, influenza, and porcine reproductive and respiratory syndrome, and the application areas include livestock vaccines, and companion animal vaccines.

What Is The Veterinary Vaccines Market Growth Forecast?

The veterinary vaccines market size is expected to see strong growth in the next few years. It will grow to $16.79 billion in 2030 at a compound annual growth rate (CAGR) of 6.0%. The growth in the forecast period can be attributed to emerging biopharmaceutical vaccine technologies, rising demand for preventive veterinary care, adoption of dna and recombinant vaccines, expansion of vaccination programs in emerging markets, increasing awareness of zoonotic disease prevention. Major trends in the forecast period include development of novel livestock vaccines, growth in companion animal vaccination programs, expansion of recombinant and toxoid vaccines, adoption of multi-disease combination vaccines, focus on preventing zoonotic disease transmission.

Global Veterinary Vaccines Market Segmentation

1) By Vaccine Type: Live Attenuated, Inactivated (Killed), Recombinant Or Subunit, mRNA And DNA, Other Vaccine Types 2) By Animal Type: Canine, Feline, Equine, Bovine, Swine, Poultry, Other Animal Types 3) By Disease Type: Viral Diseases, Bacterial Diseases, Parasitic Diseases, Other Disease Types 4) By Route Of Administration: Injectable, Oral, Intranasal, Other Route Of Administrations 5) By End-User Or Customer Type: Pet Owners Or Companion Animal Owners, Farm Or Livestock Owners, Veterinary Clinics Or Hospitals, Animal Shelters Or Rescue Organizations, Research Or Educational Institutions Subsegments: 1) By Live Attenuated: Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines 2) By Inactivated (Killed): Viral Vaccines, Bacterial Vaccines, Parasitic Vaccines 3) By Recombinant Or Subunit: Viral Vaccines, Bacterial Vaccines 4) By mRNA And DNA: Viral Vaccines, Bacterial Vaccines 5) By Other Vaccine Types: Toxoid Vaccines, Conjugate Vaccines, Vector-based Vaccines

What Is The Driver Of The Veterinary Vaccines Market?

The increase in the number of animals suffering from a range of diseases is expected to propel the growth of veterinary vaccine market going forward. Animals suffering from a range of diseases refers to non-human animals experiencing the concurrent or sequential burden of multiple pathological conditions, resulting in compounded physical, psychological, and functional harm that severely compromises their welfare. The increase in the number of animals suffering from a range of diseases is rising due to poor sanitation and hygiene conditions in animal habitats. Veterinary vaccines support animals suffering from a range of diseases by stimulating their immune systems to prevent infections, reduce disease severity, limit transmission, and enhance overall animal health and welfare. For instance, July 2025, according to the UK Health Security Agency, a UK-based government agencies, in 2024, 154 confirmed and probable leptospirosis cases (a bacterial zoonotic infection) were reported, an 11.6% increase from the 138 cases recorded in 2023. Therefore, the increase in the number of animals suffering from a range of diseases is driving the growth of the veterinary vaccine industry.

Key Players In The Global Veterinary Vaccines Market

Major companies operating in the veterinary vaccines market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck & Co. Inc., Elanco Animal Health Incorporated, Ceva Santé Animale., Virbac Group, HIPRA, Biogenesis Bago, Kyoritsu Seiyaku Corporation, Phibro Animal Health Corporation, Century Vaccines Limited, Bayer Animal Health, Cadila Vaccines Ltd., Cargill India Pvt. Ltd., China Animal Healthcare Ltd., Jurox Pty Ltd, Nimrod Veterinary Products Ltd., Bimeda, Animalcare, MSD Animal Health, Interfeed, Biotex Plus Ltd., Belfarmacom, IDT Biologika, UCBVET, Lemavet, Syntec, Sauvet, Vetanco, Chemo Argentina, Brouwer, Agrovet Market Animal Health, DBK Pharma S.A.E.

Global Veterinary Vaccines Market Trends and Insights

Major companies operating in the veterinary vaccine market are innovating new products to secure a competitive lead in the market. New products refer to advanced and disease-specific veterinary vaccines incorporating improved formulations, broader pathogen coverage, and enhanced safety and efficacy profiles. For instance, in June 2023, Merck Animal Health, a US-based pharmaceutical company launched a new three-in-one swine vaccine called Circumvent CML. This vaccine provides protection against Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsoniaintracellularis. The vaccine combines multiple antigens and adjuvant systems in a single bottle, reducing the required volume. It is administered as a single dose intramuscularly to pigs aged three weeks or older, simplifying the vaccination process and reducing stress for both animals and caretakers.

What Are Latest Mergers And Acquisitions In The Veterinary Vaccines Market?

In April 2024, Virbac SA, a France based provider of comprehensive animal health products and services, acquired Sasaeah Pharmaceutical Co. Ltd. for an undisclosed amount. With this acquisition, Virbac aimed to bolster its presence in the Asia Pacific animal health market and enhance its vaccine and pharmaceutical product portfolio particularly in farm animal segments by integrating Sasaeah’s established manufacturing, R&D capabilities, and strong regional distribution network. Sasaeah Pharmaceutical Co. Ltd. is a Japan-based animal health company that develops, manufactures, and markets a broad range of veterinary pharmaceutical products and vaccines for major species, including cattle and other farm animals, supported by manufacturing and R&D facilities in Japan and Vietnam.

Regional Outlook

North America was the largest region in the veterinary vaccines market in 2025. Asia-Pacific was the second-largest region in the global veterinary vaccines market analysis. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Veterinary Vaccines Market?

The veterinary vaccines market consists of sales of messenger RNA vaccine, viral vector vaccine, and subunit vaccine. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.